We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ADIL market cap is 6.8M. The company's latest EPS is USD -0.7997 and P/E is -1.34.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -825k | -1.36M | -1.98M | -2.04M | -2.51M |
| Net Income | 1.09M | -1.39M | -1.92M | -6.48M | -2.46M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.25M | -10.93M | -17.74M | -13.32M | -7.08M |
| Net Income | -8.59M | -10.89M | -19.42M | -12.73M | -5.12M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.78M | 2.87M | 4.74M | 6.68M | 4.95M |
| Total Liabilities | 462k | 528k | 653k | 562k | 672k |
| Total Equity | 3.32M | 2.34M | 4.08M | 6.12M | 4.28M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.68M | 5.49M | 7.48M | 5.73M | 4.74M |
| Total Liabilities | 539k | 1.51M | 3.97M | 2.46M | 653k |
| Total Equity | 7.14M | 3.99M | 3.51M | 3.28M | 4.08M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.19M | -5.58M | -6.81M | -1.63M | -3.77M |
| Investing | 800k | 1.15M | 1.5M | N/A | N/A |
| Financing | 610k | 748k | 4.13M | 3.82M | 4.24M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.34M | -7.63M | -11.95M | -11.19M | -6.81M |
| Investing | N/A | -350k | -34k | N/A | 1.5M |
| Financing | 9.25M | 5.61M | 13.64M | 9.13M | 4.13M |
| Market Cap | 6.8M |
| Price to Earnings Ratio | -1.34 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.42 |
| Price to Book Ratio | 1.68 |
| Dividend Yield | - |
| Shares Outstanding | 6.41M |
| Average Volume (1 week) | 131.08k |
| Average Volume (1 Month) | 216.39k |
| 52 Week Change | -44.39% |
| 52 Week High | 4.12 |
| 52 Week Low | 0.765 |
| Spread (Intraday) | 0.01 (0.93%) |
| Company Name | Adial Pharmaceuticals Inc |
| Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
| Website | https://www.adialpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
